Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital

Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital

By: IPP Bureau

Last updated : June 03, 2022 8:52 am



The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.


The Lockwood Group (Lockwood), an industry leader in scientific-based medical communications for the pharmaceutical, biotech, and medical device industries, announced that it has acquired Random42 (Random42), a best-in-class medical animation studio based in London, England from Graphite Capital. The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.

"Lockwood's commitment to innovative scientific communications is further bolstered by this addition of Random42 and the cutting-edge creative work that they do," said Lockwood Founder & CEO, Matt Schecter.

"As new therapies become more and more complex the need to visualize the uniqueness of their product helps our clients differentiate their brand in a sometimes-crowded marketplace. Our customers will be astounded by the visually compelling animations, virtual reality, augmented reality, holographic, and interactive experiences created in-house by Random42's expert scientific, creative, animation, and production teams. As our clients have shared their need for imaginative solutions to breakthrough crowded markets, most recently through digital channels, we are excited to bring these inventive solutions forward immediately."

Random42's executive management team, led by Medical Director & CEO Ben Ramsbottom, PhD and CFO Andy Kay in partnership with Lockwood's executive team led by Schecter and President & COO Alan Banner, will continue to guide the agencies with an emphasis on growth, capability expansion, and providing leading scientific thinking to our life science clients.

"We were impressed by Lockwood’s deep scientific bench as well as the agency's track record of successfully growing its innovative medical communications business. They share our vision for expanding the company and their expertise will be invaluable as we extend Random42's footprint to the US, enter new markets, and work with new and existing customers," said Ramsbottom.  In addition, he commented "I would like to thank the team at Graphite Capital for their partnership in helping to grow Random42."

The Lockwood Group Matt Schecter Random42 Graphite Capital Ben Ramsbottom Alan Banner

First Published : June 03, 2022 12:00 am